258 related articles for article (PubMed ID: 21098088)
1. Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients.
Moltzahn F; Olshen AB; Baehner L; Peek A; Fong L; Stöppler H; Simko J; Hilton JF; Carroll P; Blelloch R
Cancer Res; 2011 Jan; 71(2):550-60. PubMed ID: 21098088
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
3. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer.
Liu R; Chen X; Du Y; Yao W; Shen L; Wang C; Hu Z; Zhuang R; Ning G; Zhang C; Yuan Y; Li Z; Zen K; Ba Y; Zhang CY
Clin Chem; 2012 Mar; 58(3):610-8. PubMed ID: 22194634
[TBL] [Abstract][Full Text] [Related]
4. A panel of five circulating microRNAs as potential biomarkers for prostate cancer.
Chen ZH; Zhang GL; Li HR; Luo JD; Li ZX; Chen GM; Yang J
Prostate; 2012 Sep; 72(13):1443-52. PubMed ID: 22298030
[TBL] [Abstract][Full Text] [Related]
5. Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.
Kachakova D; Mitkova A; Popov E; Popov I; Vlahova A; Dikov T; Christova S; Mitev V; Slavov C; Kaneva R
DNA Cell Biol; 2015 Mar; 34(3):189-200. PubMed ID: 25521481
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
[TBL] [Abstract][Full Text] [Related]
7. High throughput microRNA profiling: optimized multiplex qRT-PCR at nanoliter scale on the fluidigm dynamic arrayTM IFCs.
Moltzahn F; Hunkapiller N; Mir AA; Imbar T; Blelloch R
J Vis Exp; 2011 Aug; (54):. PubMed ID: 21847076
[TBL] [Abstract][Full Text] [Related]
8. A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer.
Daniel R; Wu Q; Williams V; Clark G; Guruli G; Zehner Z
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621736
[TBL] [Abstract][Full Text] [Related]
9. Combining PHI and miRNAs as Biomarkers in Prostate Cancer Diagnosis and Prognosis.
Ibrahim NH; Abdellateif MS; Thabet G; Kassem SH; El-Salam MA; El-Leithy AA; Selim MM
Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307177
[TBL] [Abstract][Full Text] [Related]
10. Identification of prostate cancer-associated microRNAs in circulation using a mouse model of disease.
Selth LA; Townley SL; Gillis JL; Tilley WD; Butler LM
Methods Mol Biol; 2013; 1024():235-46. PubMed ID: 23719956
[TBL] [Abstract][Full Text] [Related]
11. A study of circulating microRNAs identifies a new potential biomarker panel to distinguish aggressive prostate cancer.
Farran B; Dyson G; Craig D; Dombkowski A; Beebe-Dimmer JL; Powell IJ; Podgorski I; Heilbrun L; Bolton S; Bock CH
Carcinogenesis; 2018 Apr; 39(4):556-561. PubMed ID: 29471417
[TBL] [Abstract][Full Text] [Related]
12. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer.
Sharma N; Baruah MM
Clin Transl Oncol; 2019 Feb; 21(2):126-144. PubMed ID: 29951892
[TBL] [Abstract][Full Text] [Related]
13. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
[TBL] [Abstract][Full Text] [Related]
14. Cell-Free miRNA-141 and miRNA-205 as Prostate Cancer Biomarkers.
Osipov ID; Zaporozhchenko IA; Bondar AA; Zaripov MM; Voytsitskiy VE; Vlassov VV; Laktionov PP; Morozkin ES
Adv Exp Med Biol; 2016; 924():9-12. PubMed ID: 27753010
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer.
Martens-Uzunova ES; Jalava SE; Dits NF; van Leenders GJ; Møller S; Trapman J; Bangma CH; Litman T; Visakorpi T; Jenster G
Oncogene; 2012 Feb; 31(8):978-91. PubMed ID: 21765474
[TBL] [Abstract][Full Text] [Related]
17. Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.
Leidinger P; Hart M; Backes C; Rheinheimer S; Keck B; Wullich B; Keller A; Meese E
Tumour Biol; 2016 Aug; 37(8):10177-85. PubMed ID: 26831660
[TBL] [Abstract][Full Text] [Related]
18. microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer.
Zedan AH; Hansen TF; Assenholt J; Pleckaitis M; Madsen JS; Osther PJS
Tumour Biol; 2018 May; 40(5):1010428318775864. PubMed ID: 29775158
[TBL] [Abstract][Full Text] [Related]
19. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer.
Guzel E; Karatas OF; Semercioz A; Ekici S; Aykan S; Yentur S; Creighton CJ; Ittmann M; Ozen M
Int J Cancer; 2015 Feb; 136(4):875-9. PubMed ID: 24976077
[TBL] [Abstract][Full Text] [Related]
20. Circulating miRNAs are correlated with tumor progression in prostate cancer.
Brase JC; Johannes M; Schlomm T; Fälth M; Haese A; Steuber T; Beissbarth T; Kuner R; Sültmann H
Int J Cancer; 2011 Feb; 128(3):608-16. PubMed ID: 20473869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]